NCT06466109

Brief Summary

The goals of this clinical trial are to (a) evaluate the feasibility and acceptability of a social robot intervention for providing family-based care for rare diseases families and (b) explore the effectiveness of the social robot intervention in improving the parent-child relationships and alleviating stress and anxiety for rare diseases patients and their parents. The main questions are:

  • Is the social robot intervention suitable for and acceptable to rare disease patients and parents?
  • Does the social robot intervention improve the parent-child relationship of rare disease patients and their parents?
  • Does the social robot intervention alleviate the stress and anxiety of rare disease patients and their parents? Patients and their parents will interact with the social robot PARO separately and together in each 30-minute course every two weeks for four courses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2024

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 20, 2024

Completed
22 days until next milestone

Study Start

First participant enrolled

July 12, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 27, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 27, 2025

Completed
Last Updated

April 13, 2026

Status Verified

August 1, 2025

Enrollment Period

1.1 years

First QC Date

May 24, 2024

Last Update Submit

April 7, 2026

Conditions

Keywords

RoboticsParent-Child RelationsAnxietyStress, PsychologicalRare Diseases

Outcome Measures

Primary Outcomes (5)

  • retention rate

    The retention rate is the average percentage of the patient-parent dyads who complete the 4-course intervention.

    immediately after the intervention

  • acceptability

    The unified theory of acceptance and use of technology (UTAUT) scale will measure participants' acceptability of the social robot intervention. The chosen domains of this scale are perceived sociability (4 items), social presence (5 items), and perceived enjoyment (5 items) due to the importance of social robot interaction and sociability. Each item is assessed on a 5-point Likert scale, varying from 1 to 5; each domain's score is summed up individually; higher scores represent more agreement with this domain.

    immediately after the intervention

  • parent-child relationship

    The elementary school student parent-child relationship scale will measure the patient's perceived parent-child relationship. The scale is composed of a 25-item questionnaire. Each item is assessed on a 5-point Likert scale, varying from 1 to 5, with total points ranging from 25 to 125, with higher scores representing better parent-child relationships. As for the parent's perceived parent-child relationship, the researcher modified part of the elementary school student parent-child relationship scale, and a psychological specialist validated the content. The score calculation is similar to the elementary school student parent-child relationship scale.

    immediately after the intervention

  • anxiety

    The Chinese Version of the State Anxiety Scale for Children will measure the patient's anxiety. The scale is composed of a 20-item questionnaire. Each item is assessed on a 3-point Likert scale, varying from 1 to 3, with total points ranging from 20 to 60, with higher scores representing higher anxiety. The State-Trait Anxiety Inventory-State Anxiety will measure the parent's anxiety. The scale is composed of a 20-item questionnaire. Each item is assessed on a 4-point Likert scale, varying from 1 to 4, with total points ranging from 20 to 80, with higher scores representing higher anxiety.

    immediately after the intervention

  • stress

    The heart rate variability and the Perceived Stress Scale will measure the patient's and the parent's stress. The researcher uses " Taiwan Scientific" Non-invasive Blood Pressure Meter to measure the heart rate variability, recording the low frequency power (LF), high frequency power (HF), and the ratio LF (ms2)/HF (ms2). The Perceived Stress Scale is composed of a 10-item questionnaire. Each item is assessed on a 5-point Likert scale, varying from 0 to 4, with total points ranging from 0 to 40, with higher scores representing higher perceived stress.

    immediately after the intervention

Secondary Outcomes (1)

  • child-parent-robot interaction

    immediately after the intervention

Study Arms (1)

intervention group

EXPERIMENTAL

Patients and their parents will interact with the social robot PARO separately and together in each 30-minute course every two weeks for four courses.

Behavioral: social robot intervention

Interventions

In the first and second courses, the patients and their parents freely interact with the social robot PARO for 30 minutes. In the third course, patients and their parents interact with PARO for 30 minutes using a worksheet that includes naming and recording characteristics of PARO. In the last course, patients and their parents interact with PARO for 30 minutes using a worksheet that freely recorded their observations about PARO and say goodbye to it.

intervention group

Eligibility Criteria

Age8 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • \[Patients\]
  • Aged 8 to 19 years.
  • Diagnosed with a rare disease.
  • Be Able to communicate in Chinese. \[Parents\]
  • A father or a mother of a child with a rare disease.
  • Be Able to communicate in Chinese.

You may not qualify if:

  • \[Patients\]
  • Have a pacemaker.
  • Have open wounds.
  • Being infected with infectious diseases.
  • Be unable to participate in social activities due to severe psychological disorder or cognitive dysfunction.
  • \[Parents\]
  • Have a pacemaker.
  • Have open wounds.
  • Being infected with infectious diseases.
  • Be unable to participate in social activities due to severe psychological disorder or cognitive dysfunction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

National Taiwan University Children's Hospital

Taipei, 100226, Taiwan

Location

Taipei Veterans General Hospital

Taipei, 11217, Taiwan

Location

MeSH Terms

Conditions

Rare DiseasesAnxiety DisordersStress, Psychological

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsMental DisordersBehavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: A single-group, pretest-posttest clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2024

First Posted

June 20, 2024

Study Start

July 12, 2024

Primary Completion

August 27, 2025

Study Completion

August 27, 2025

Last Updated

April 13, 2026

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations